The US FDA is responsible for the down-turn in new drug approvals
Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1646, 2008-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Access to resources
Recommend
